Trial · NCT01010282
Adverse events33
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 33
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Visual acuity reduced | Eye disorders | Artificial Tears Formulation 1 | 16 | 97 | |
| other | Visual acuity reduced | Eye disorders | Artificial Tears Formulation 2 | 7 | 95 | |
| other | Visual acuity reduced | Eye disorders | Glycerin and Polysorbate 80 Based Artificial Tear | 11 | 96 | |
| other | Vision blurred | Eye disorders | Artificial Tears Formulation 1 | 5 | 97 | |
| other | Vision blurred | Eye disorders | Artificial Tears Formulation 2 | 3 | 95 | |
| other | Vision blurred | Eye disorders | Glycerin and Polysorbate 80 Based Artificial Tear | 7 | 96 | |
| other | Eye pain | Eye disorders | Artificial Tears Formulation 1 | 3 | 97 | |
| other | Eye pain | Eye disorders | Artificial Tears Formulation 2 | 1 | 95 | |
| other | Eye pain | Eye disorders | Glycerin and Polysorbate 80 Based Artificial Tear | 6 | 96 | |
| other | Photophobia | Eye disorders | Artificial Tears Formulation 1 | 3 | 97 | |
| other | Photophobia | Eye disorders | Artificial Tears Formulation 2 | 1 | 95 | |
| other | Photophobia | Eye disorders | Glycerin and Polysorbate 80 Based Artificial Tear | 5 | 96 | |
| other | Instillation site pain | General disorders | Artificial Tears Formulation 1 | 1 | 97 | |
| other | Instillation site pain | General disorders | Artificial Tears Formulation 2 | 2 | 95 | |
| other | Instillation site pain | General disorders | Glycerin and Polysorbate 80 Based Artificial Tear | 8 | 96 | |
| serious | Abortion induced | Surgical and medical procedures | Artificial Tears Formulation 1 | 1 | 97 | |
| serious | Abortion induced | Surgical and medical procedures | Artificial Tears Formulation 2 | 0 | 95 | |
| serious | Abortion induced | Surgical and medical procedures | Glycerin and Polysorbate 80 Based Artificial Tear | 0 | 96 | |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Artificial Tears Formulation 1 | 1 | 97 | |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | Artificial Tears Formulation 2 | 0 | 95 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01010282/events